Literature DB >> 36408

Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting.

A Balsam, S H Ingbar.   

Abstract

Studies were performed to explore the mechanism underlying the impaired generation of 125-I-3,5,3'-triiodothyronine (T3) from 125I-thyroxine (T4) (T3-neogenesis)) in preparations of liver from rats fasted for 48 h and the prevention of this effect by the feeding of glucose. T3-neogenesis in livers from fasted animals and those fed chow or glucose was assessed in various mixtures of crude microsomal fractions with either buffer or cytosols. T3-neogenesis was mediated by an enzyme present in the microsomal fraction whose activity was enhanced by cytosolic cofactor(s). In livers from animals fasted for 48 h, the supporting activity of cytosol was decreased, whereas the activity of the enzyme was unaffected. Administration of glucose as the sole nutritional source prevented the decrease in the supporting activity of hepatic cytosol that was regularly observed in the case of animals totally deprived of food. The diminished supporting activity for T3-neogenesis provided by liver cytosol from fasted animals was restored to normal by enrichment with either NADPH or GSH, but the two cofactors appeared to act at different loci. GSH stimulated T3-neogenesis in microsomes incubated in the absence of cytosol, i.e., in buffer, whereas NADPH did not. The stimulatory effect of both agents was blocked by the sulfhydryl oxidant, diamide, which also inhibited T3-neogenesis in mixtures of microsomes with cytosols. Taken together, these observations suggest that GSH acts directly on the enzyme in the crude microsomal fraction, whereas NADPH acts within the cytosol, possibly by increasing the concentration of GSH through the action of the enzyme glutathione reductase, for which NADPH is a cofactor. In this light, the decreased supporting activity of hepatic cytosol from starved animals appears to reflect, at least partly, a decreased concentration of one or both cofactors. The direct stimulation of enzyme activity by GSH, and the apparent lack of inhibition of unstimulated activity by diamide, suggests that the 5'-monodeiodinase for thyroxine that mediates T3-neogenesis may be a GSH transhydrogenase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36408      PMCID: PMC372062          DOI: 10.1172/JCI109408

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  The hexosemonophosphate shunt and adaptive hyperlipogenesis.

Authors:  H M TEPPERMAN; J TEPPERMAN
Journal:  Diabetes       Date:  1958 Nov-Dec       Impact factor: 9.461

2.  The enzymatic reduction of delta 4-3-ketosteroids.

Authors:  G M TOMKINS
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

3.  Sulfhydryl factors in degradation of insulin-I131 by liver extracts.

Authors:  H T NARAHARA; H H TOMIZAWA; R H WILLIAMS
Journal:  Proc Soc Exp Biol Med       Date:  1956 Aug-Sep

4.  Effect of caloric restriction and dietary composition of serum T3 and reverse T3 in man.

Authors:  S W Spaulding; I J Chopra; R S Sherwin; S S Lyall
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

5.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

6.  Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting.

Authors:  A G Vagenakis; A Burger; G I Portnary; M Rudolph; J R O'Brian; F Azizi; R A Arky; P Nicod; S H Ingbar; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

7.  Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents.

Authors:  H Bürgi; C Wimpfheimer; A Burger; W Zaunbauer; H Rösler; T Lemarchand-Béraud
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

8.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

10.  Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.

Authors:  M Saberi; F H Sterling; R D Utiger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

View more
  14 in total

Review 1.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

2.  Relationships between iodothyronine peripheral metabolism and ketone bodies during hypocaloric dietary manipulations.

Authors:  R Pasquali; G Baraldi; P Biso; F Pasqui; L Mattioli; M Capelli; R Callivá; M Spoto; N Melchionda; G Labò
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

3.  Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.

Authors:  H F Escobar-Morreale; M J Obregón; F Escobar del Rey; G Morreale de Escobar
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

5.  Inhibition of rat hepatic thyroxine 5'-monodeiodinase by propylthiouracil: relation to site of interaction of thyroxine and glutathione.

Authors:  T Yamada; I J Chopra; N Kaplowitz
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

6.  NADPH-dependent generation of a cytosolic dithiol which activates hepatic iodothyronine 5'-deiodinase. Demonstration by alkylation with iodoacetamide.

Authors:  A K Das; B C Hummel; P G Walfish
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

7.  Formation of diiodotyrosine from thyroxine. Ether-link cleavage, an alternate pathway of thyroxine metabolism.

Authors:  A Balsam; F Sexton; M Borges; S H Ingbar
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

8.  Selenium content of livers from sex-linked dwarf and normal broiler breeders. Influence of a thyrotropin-releasing hormone-induced growth hormone release.

Authors:  E Kühn; R Van Cauwenbergh; L Huybrechts; H Deelstra
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

9.  Intermediate Mr cytosolic components potentiate hepatic 5'-deiodinase activation by thiols.

Authors:  K Sawada; B C Hummel; P G Walfish
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

10.  Dietary modification of thyroxine deiodination in rat liver is not mediated by hepatic sulfhydryls.

Authors:  L A Gavin; F A McMahon; M Moeller
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.